
USD
$0.00
(0.00%
)At Close (As of Dec 12, 2025)
$21.32M
Market Cap
-
P/E Ratio
-2.26
EPS
$17.20
52 Week High
$1.45
52 Week Low
TECHNOLOGY
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | $41K |
| Total Revenue | $108K |
| Cost Of Revenue | $67K |
| Costof Goods And Services Sold | $67K |
| Operating Income | -$9.2M |
| Selling General And Administrative | $6.1M |
| Research And Development | $2M |
| Operating Expenses | $9.2M |
| Investment Income Net | - |
| Net Interest Income | -$69K |
| Interest Income | - |
| Interest Expense | $69K |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $67K |
| Income Before Tax | -$10M |
| Income Tax Expense | $2K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$10M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$10M |
| Ebitda | -$10M |
| Net Income | -$10M |
| Field | Value (USD) |
|---|---|
| Gross Profit | $41K |
| Total Revenue | $108K |
| Cost Of Revenue | $67K |
| Costof Goods And Services Sold | $67K |
| Operating Income | -$9.2M |
| Selling General And Administrative | $6.1M |
| Research And Development | $2M |
| Operating Expenses | $9.2M |
| Investment Income Net | - |
| Net Interest Income | -$69K |
| Interest Income | - |
| Interest Expense | $69K |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $67K |
| Income Before Tax | -$10M |
| Income Tax Expense | $2K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$10M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$10M |
| Ebitda | -$10M |
| Net Income | -$10M |
Sector: TECHNOLOGY
Industry: SOFTWARE - APPLICATION
Firefly Neuroscience, Inc. is an innovative Toronto-based medical technology firm dedicated to transforming the treatment landscape for mental illnesses and neurological disorders through the application of artificial intelligence and advanced neuroscientific solutions. By harnessing state-of-the-art AI analytics, Firefly is at the forefront of addressing critical gaps in mental health care, thereby enhancing patient outcomes and fostering improved therapeutic interventions. Positioned within a rapidly expanding healthcare technology sector, the company's commitment to cutting-edge research and development presents compelling opportunities for institutional investors looking to capitalize on emerging advancements in the field.